Back to RARE
Essential Partners LLC RARE Position History
Ultragenyx Pharmaceutical Inc. • Healthcare
Quarters held
5
Latest value
$947
Q3 2026
Peak value
$53K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $3K |
| Q4 2025 | $39K |
| Q1 2026 | $20K |
| Q2 2026 | $53K |
| Q3 2026 | $947 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $947 | 63 | — | — |
| Q2 2026 | $53K | 1.6K | — | — |
| Q1 2026 | $20K | 968 | — | — |
| Q4 2025 | $39K | 1.7K | — | — |
| Q3 2025 | $3K | 89 | — | — |
Other funds holding RARE
$365.5M
$356.7M
$283.9M
$219.1M
$213.3M
$205.6M
$205.6M
$155.5M